Brett Hurst
Animal, Dairy & Vet Sciences
Antiviral Research
Educational Background
Biography
Dr. Hurst has worked for the Institute for Antiviral Research since 2006. He completed his M.S. working with influenza virus and his Ph.D. with Enteroviruses.
Teaching Interests
Virology
Biotechnology
Antiviral Therapies
Research Interests
Evaluation of antiviral therapies in cell culture an animal models of disease. I have a particular focus on influenza viruses, picornaviruses, and of course coronaviruses. Our focus at the Institute for Antiviral Research is to recognize emerging viral infectious diseases and establish cell culture and animal models to evaluate therapies and vaccines.
Awards
1st Place Ph.D. Oral Presentation, 2018
Animal, Dairy, and Veterinary Science Student Research Symposium
Poster Award, 2018
International Society for Antiviral Research
Publications | Journal Articles
Academic Journal
- Honda-Okubo, Y., Sakala, I.G, Andre, F., Tarbet, B., Hurst, B., Petrovsky, N., (2023). An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice. Vaccine, 5592-5602. doi: 10.1016/j.vaccine.2023.07.061
- Lane, T.R, Fu, J., Sherry, B., Tarbet, B., Hurst, B., Riabova, O., Kazakova, E., Egorova, A., Clarke, P., Leser, J.S, Frost, J., Rudy, M., Tyler, K.L, Klose, T., Volobueva, A.S, Velyaevskaya, S.V, Zarubaev, V.V, Kuhn, R.J, Makarov, V., Ekins, S., (2023). Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5. Antiviral Research, doi: 10.1016/j.antiviral.2023.105654
- Spengler, J.R, Carter, K., Delang, L., Durantel, D., Gowen, B., Herrero, L.J, Hurst, B., Janeba, Z., Jordan, R., Luo, D., Meier, C., Moffat, J., Rocha-Pereira, J., Seley-Radtke, K.L, Welch, S.R, Schang, L.M, (2023). Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023. Antiviral Research, 217, 105678. doi: https://doi.org/10.1016/j.antiviral.2023.105678
- Peterson, C.J, Hurst, B., Evans, W., Van Wettere, A., Gibson, S.A, Smee, D.F, Tarbet, B., (2023). Human IVIG treatment in a neurological disease model for Enterovirus A71 infection in 28-day-old AG129 mice. Virology580, 62-72. doi: 10.1016/j.virol.2023.02.002
- Owen, D.R, Allerton, C.M, Anderson, A.S, Aschenbrenner, L., Avery, M., Berritt, S., Boras, B., Cardin, R.D, Carlo, A., Coffman, K.J, Dantonio, A., Di, L., Eng, H., Ferre, R., Gajiwala, K.S, Gibson, S.A, Greasley, S.E, Hurst, B.L, Kadar, E.P, Kalgutkar, A.S, Lee, J.C, Lee, J., Liu, W., Mason, S.W, Noell, S., Novak, J.J, Obach, R.S, Ogilvie, K., Patel, N.C, Petterson, M., Rai, D.K, Reese, M.R, Sammons, M.F, Sathish, J.G, Singh, R.S, Steppan, C.M, Stewart, A.E, Tuttle, J.B, Updyke, L., Verhoest, P.R, Wei, L., Yang, Q., Zhu, Y., (2021). An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science, 374:6575, 1586-1593. doi: 10.1126/science.abl4784
An asterisk (*) at the end of a publication indicates that it has not been peer-reviewed.
Publications | Other
An asterisk (*) at the end of a publication indicates that it has not been peer-reviewed.